In our study, a positive association between sclerostin levels with insulin and HOMA-IR was found in control subjects without NAFLD, while a negative correlation was found between sclerostin and HOMA-IR in NAFLD subjects. The gene discussed is SOST; the disease is metabolic dysfunction-associated steatotic liver disease.